ERCC1 and XPD/ERCC2 Polymorphisms' Predictive Value of Oxaliplatin-Based Chemotherapies in Advanced Colorectal Cancer has an Ethnic Discrepancy: A Meta-analysis

ERCC1 XPD/ERCC2polymorphismoxaliplatin-based chemotherapycolorectal cancerMeta-analysis